Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.62 |
| ▸ | L3MBTL3 | Q96JM7 | 6/20 | 0.62 |
| ▸ | MBTD1 | Q05BQ5 | 2/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9367020 | 0.98 | HRH3 (0.66) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| SCHEMBL422200 | 0.82 | SIGMAR1 (0.56) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| SCHEMBL27896085 | 0.82 | SIGMAR1 (0.54) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| SCHEMBL6232146 | 0.82 | KCNH2 (0.55) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| Water SCHEMBL3683452 | 0.81 | SLC6A3 (0.96) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| 1-Phenethylpiperidine SCHEMBL11404041 | 0.79 | SIGMAR1 (0.96) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| 1-Phenethylpiperidine SCHEMBL27451069 | 0.79 | SIGMAR1 (0.96) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| 1-Phenethylpiperidine SCHEMBL7524827 | 0.79 | SIGMAR1 (0.96) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| SCHEMBL2876271 | 0.78 | SLC6A3 (1.00) | SLC6A3HRH3L3MBTL1L3MBTL3MBTD1 | |
| SCHEMBL738784 | 0.78 | HRH3 (0.67) | HRH3L3MBTL1L3MBTL3MBTD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209190-A1 | CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, RUBBER-CROSSLINKED SUBSTANCE, AND TIRE | ZS ELASTOMERS CO., LTD. (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3604365-B1 | CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING CONJUGATED DIENE POLYMER | SUMITOMO CHEMICAL CO (JP) | 2024-04-24 | — | — | EP | disclosed |
| CN-113748134-B | Conjugated diene copolymer and method for producing conjugated diene copolymer | 瑞住合成橡胶株式会社 | 2024-03-08 | — | — | CN | disclosed |
| EP-4331862-A1 | CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, RUBBER-CROSSLINKED SUBSTANCE, AND TIRE | ZS Elastomers Co., Ltd. (JP) | 2024-03-06 | — | — | EP | disclosed |
| CN-117222674-A | Conjugated diene polymer, rubber composition, rubber crosslinked product, and tire | 瑞住合成橡胶株式会社 | 2023-12-12 | — | — | CN | disclosed |
| CN-110461893-B | Conjugated diene polymer and method for producing conjugated diene polymer | 住友化学株式会社 | 2023-10-27 | — | — | CN | disclosed |
| WO-2023145652-A1 | OIL-EXTENDED CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, CROSSLINKED RUBBER PRODUCT, AND TIRE | ＺＳエラストマー株式会社 | 2023-08-03 | — | — | WO | disclosed |
| EP-3495394-B1 | METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING POLYMER COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2023-04-12 | — | — | EP | disclosed |
| US-11377513-B2 | Conjugated diene polymer and method for producing conjugated diene polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20220185919-A1 | CONJUGATED DIENE COPOLYMER AND METHOD FOR MANUFACTURING CONJUGATED DIENE COPOLYMER | ZS ELASTOMERS CO., LTD. (JP) | 2022-06-16 | — | — | US | disclosed |
| US-20120190770-A1 | PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER, AND CONJUGATED DIENE-BASED POLYMER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED | 2012-07-26 | — | — | US | disclosed |
| US-20120190771-A1 | PROCESS FOR PRODUCING CONJUGATED DIENE-BASED POLYMER, CONJUGATED DIENE-BASED POLYMER, AND CONJUGATED DIENE-BASED POLYMER COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED | 2012-07-26 | — | — | US | disclosed |
| CN-102603974-A | Process for producing conjugated diene-based polymer, conjugated diene-based polymer, and conjugated diene-based polymer composition | SUMITOMO CHEMICAL CO | 2012-07-25 | — | — | CN | disclosed |
| CN-102603975-A | Method for producing conjugated diene polymer, and conjugated diene polymer composition | SUMITOMO CHEMICAL CO | 2012-07-25 | — | — | CN | disclosed |
| WO-2011137022-A1 | AZAINDOLES AS JANUS KINASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2011-11-03 | — | — | WO | disclosed |
| US-20100267721-A1 | Heterocyclic H3 Antagonists | HIGH POINT PHARMACEUTICALS LLC (US) | 2010-10-21 | — | — | US | disclosed |
| EP-2166850-A1 | NEW HETEOCYCLIC H3 ANTAGONISTS | High Point Pharmaceuticals, LLC (US) | 2010-03-31 | — | — | EP | disclosed |
| EP-2014656-A2 | New heteocyclic h3 antagonists | TRANSTECH PHARMA (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008154126-A1 | NEW HETEOCYCLIC H3 ANTAGONISTS | HIGH POINT PHARMACEUTICALS, LLC (US) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008020203-A1 | PYRIDINYLQUINAZ0LINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS | ASTRAZENECA AB (SE) | 2008-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267721-A1 | Heterocyclic H3 Antagonists | HRH3, HRH4, HRH2 | SLC6A3 419/4885HRH3 1/4885L3MBTL1 2451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.